Femme et Homme
- | Pays :
- Russian Federation
- Hungary
- Switzerland
- Les 21 autres...
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the safety, tolerability and efficacy of 3 doses of vernakalant (oral) (150 mg, 300 mg and 500 mg b.i.d.) administered for up to 90 days in subjects with sustained symptomatic atrial fibrillation (AF duration > 72 hours and < 6 months).
Critère d'inclusion
- Atrial fibrillation